Integer Announces Planned Departure of Chief Financial Officer

Published on:

FRISCO, Texas, Sept. 14, 2016 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource (MDO) manufacturer, today announced that Michael Dinkins, executive vice president and chief financial officer, plans to leave the Company. The Company has commenced a search for his successor, and Mr. Dinkins will continue to serve as executive vice president and chief financial officer for up to six months or such earlier date when his successor is named.

“I want to thank Michael for his contributions to Integer over the past eight years,” said Thomas Hook, Integer’s president and chief executive officer. “Michael was instrumental in providing strategic financial direction during the recent merger of Greatbatch Medical and Lake Region Medical, which doubled the size of our company. This has positioned us to deliver a broader suite of products and services to our customers. We appreciate Michael’s commitment to ensuring a smooth transition over the next few months and wish him well in his new endeavors.”

“I am proud of everything the Integer team has accomplished, especially over the last year,” said Dinkins. “We have made great progress integrating the Greatbatch and Lake Region companies and have already realized many synergies along the way while maintaining the integrity of our finance and tax reporting. While I look forward to pursuing theological studies and increasing my non-profit activities in my retirement, I will miss working with the great team at Integer.”

Mr. Dinkins served on the Greatbatch Board of Directors from 2008-2012. In 2012, he transitioned from a Director into the CFO role.

About Integer 
Integer Holdings Corporation (ITGR) is one of the largest medical device outsource (MDO) manufacturers in the world serving the cardiac, neuromodulation, orthopedics, vascular, advanced surgical and portable medical markets. The company provides innovative, high-quality medical technologies that enhance the lives of patients worldwide. In addition, it develops batteries for high-end niche applications in energy, military, and environmental markets. The company's brands include Greatbatch Medical, Lake Region Medical and Electrochem. Additional information is available at www.integer.net

Investor Relations:
Amy Wakeham
IR@greatbatch.com
214.618.4978

Related Content

From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy
Healthcare AI regulation needs nuance, balance: Research review
ICU diary-keeping: There’s an AI for that
Stanford HAI lookback: Best-read blog posts of 2024
Providers, payers share actionable experiences involving healthcare AI
Healthcare-specific AI: How to multiply successes and head off accidents

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.